Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Jan 11, 2023

BUY
$68.48 - $81.09 $273 - $324
4 Added 0.7%
575 $0
Q3 2022

Oct 07, 2022

BUY
$0.13 - $76.84 $0 - $307
4 Added 0.71%
571 $40,000
Q2 2022

Jul 06, 2022

SELL
$72.62 - $79.98 $39,287 - $43,269
-541 Reduced 48.83%
567 $43,000
Q4 2021

Jan 11, 2022

BUY
$53.63 - $62.52 $59,422 - $69,272
1,108 New
1,108 $69,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Paladin Advisory Group, LLC Portfolio

Follow Paladin Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paladin Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paladin Advisory Group, LLC with notifications on news.